Keyword Suggestion
Domain Informations
Glyscend.com lookup results from whois.godaddy.com server:
- Domain created: 2014-09-01T21:07:55Z
- Domain updated: 2024-09-02T14:01:07Z
- Domain expires: 2025-09-01T21:07:55Z 0 Years, 326 Days left
- Website age: 10 Years, 38 Days
- Registrar Domain ID: 1873770563_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS41.DOMAINCONTROL.COM
- NS42.DOMAINCONTROL.COM
Network
- 0 : 162.240.0.0 - 162.241.255.255,UNIFIEDLAYER-NETWORK-16,NET-162-240-0-0-1,Direct Allocation,2006-08-08,2020-01-31
- 1 : NETBLK-UL.162.240.0.0/15,UL-162.240.0.0/15,162.240.0.0/15,2012-11-19,2012-11-19
Owner
- organization : Unified Layer
- handle : BLUEH-2
- address : Array,Provo,UT,84606,US
Technical support
- handle : ENO74-ARIN
- name : EIG Network Operations
- phone : +1-877-659-6181
- email : [email protected]
Abuse
- handle : NOC2320-ARIN
- name : Network Operations Center
- phone : +1-801-765-9400
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 162.241.16.11
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Timezone: America/Denver
Site Inspections
Port Scanner (IP: 162.241.16.11)
Spam Check (IP: 162.241.16.11)
Recent Searched Sites
› Mobilearrival.com (11 seconds ago) / US
› Avinfobot.com (7 seconds ago) / US
› Gmlyrics.online (1 seconds ago) / US
› Animagirls.club (37 seconds ago) / AU
› Rpsgame.org (15 seconds ago) / US
› Willowbridgepc.com (1 seconds ago) / US
› Guldsmykket.dk (6 seconds ago) / US
› Playspades-online.com (5 seconds ago) / US
› Restorationtherapytraining.com (3 seconds ago) / US
› Bicyclecards.com (0 seconds ago) / US
› M.hellotoby.com (17 seconds ago) / SG
› Eminacheese.com (3 seconds ago) / US
› Vectorshift.ai (13 seconds ago) / US
› Dentalassistantschoolwaco.com (16 seconds ago) / US
› Ysgc1.cc (25 seconds ago) / US
› Anilibria.top (25 seconds ago) / RU
› Cardzmania.com (12 seconds ago) / US
› Online-spades.com (8 seconds ago) / US
› Drumstructor.com (9 seconds ago) / DE
› Glyscend.com (0 seconds ago) / US
Websites Listing
We found Websites Listing below when search with glyscend.com on Search Engine
Glyscend – An innovative approach to the treatment of …
Glyscend’s technology is intended to work locally in specific portions of the gastrointestinal (GI) tract by creating a temporary barrier to alter food uptake and induce dramatic changes in hormonal signaling via the gut-liver-brain axis. This technology could enable, not just the treatment but potentially a reversal of T2D. Glyscend’s non-absorbed compounds have the …
Glyscend.comAbout - Glyscend
Glyscend, Inc. is a venture-backed, clinical-stage biopharmaceutical company developing novel orally-delivered compounds that work on targets inside the GI tract to treat a variety of metabolic disorders, including T2D. Glyscend’s polymer technology platform evolved from research at Johns Hopkins University, where scientists were evaluating the mechanisms that result in …
Glyscend.comNews - Glyscend
2020-06-11 · Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes. B altimore, MD (June 11, 2020) – Glyscend Therapeutics, a privately held biopharmaceutical company developing novel treatments for type 2 diabetes (T2D) and related metabolic conditions, today announced the closing of a $20.5 ...
Glyscend.comGlyscend - Crunchbase Company Profile & Funding
Contact Email [email protected] Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current …
Crunchbase.comGlyscend Incorporated other Contacts Business Emails ...
Find the Glyscend Incorporated company's other team/department contact details such as business emails, phone numbers, web address and other details. Get …
Adapt.ioContact Us - Glysomed
Can't find what you're looking for? Feel free to Contact us for more information on Canada's leading skin care products for dry itchy skin.
Glysomed.comGlyscend Company Profile | Management and Employees List
Glyscend Therapeutics is a venture-backed biopharmaceutical company developing novel orally-delivered compounds that work on targets inside the GI tract to treat a variety of metabolic disorders, including T2D. Glyscend's polymer technology platform evolved from research at Johns Hopkins University, where scientists were evaluating the mechanisms that result in …
Datanyze.comGlyscend Therapeutics Completes $20.5M Financing Round to ...
B altimore, MD (June 11, 2020) – Glyscend Therapeutics, a privately held biopharmaceutical company developing novel treatments for type 2 diabetes (T2D) and related metabolic conditions, today announced the closing of a $20.5 million Series A financing round. Healthcare investors Brandon Capital Partners, through its Medical Research Commercialisation Fund (MRCF), and …
Glyscend.comKevin Colbert - Email, Phone - Co-Founder, Glyscend ...
Find Kevin Colbert's accurate email address and contact/phone number in Adapt.io. Currently working as Co-Founder at Glyscend Incorporated in Maryland, United States.
Adapt.ioGlyscend - MassBio
Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which acts on the same mechanism as surgery but fits within the current care …
Massbio.orgICTRP Search Portal
Email: [email protected]: Affiliation: Key inclusion & exclusion criteria: Inclusion criteria: 1. Male or female, greater than or equal to 18 and less than or equal to 65 years old at the time of screening, with BMI greater than and equal to 18.0 and less than 32kg/m2 2. Subjects must be in good general health, with no significant medical history, have no clinically significant …
Trialsearch.who.intGlyscend - $1.3 Million Revenue | Kona Equity
Glyscend (glyscend.com) in Baltimore, MD. None View more company details, employee count and revenue data on Kona Equity.
Konaequity.comGLYSCEND - Wolfram|Alpha
Compute answers using Wolfram's breakthrough technology & knowledgebase, relied on by millions of students & professionals. For math, science, nutrition, history ...
Wolframalpha.comGlyscend – Brandon Capital Partners
Glyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes. Glyscend’s polymer technology platform evolved from research at Johns Hopkins University, where scientists, in collaboration with clinicians at the Royal Adelaide Hospital were evaluating the mechanisms that result in significantly improved glucose and metabolic …
Brandoncapital.vcGlyscend Incorporated - LinkedIn
Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the ...
Linkedin.comTaylor Carlson - Email, Phone - Research Scientist ...
Find Taylor Carlson's accurate email address in Adapt.io. Currently working as Research Scientist at Glyscend Incorporated in Maryland, United States.
Adapt.ioJohn Petersen - Email, Phone - Vice President Product ...
Find John Petersen's accurate email address in Adapt.io. Currently working as Vice President Product Development at Glyscend Incorporated in Maryland, United States.
Adapt.ioGlyscend Therapeutics announces preclinical data at ADA ...
Subscribe to Email Updates. SHARE; Glyscend Therapeutics announces preclinical data at ADA 2021 on the metabolic benefits of its oral polymer-based duodenal exclusion therapy August 3, 2021 Noninvasive polymer therapy dramatically improves glucose homeostasis based on the principle of duodenal exclusion. Glyscend Inc presented data during the American Diabetes …
News.lifesciencenewswire.comGLYSCEND PTY LTD in Australia - Company Details by ...
Glyscend Pty Ltd is 1 year(s), 8 month(s) and 6 day(s) old. Registration Details. Company Name: GLYSCEND PTY LTD. ABN Number: 24640395615. Status: REGD. Type: APTY. Class: LMSH. Sub Class: PROP. Incorporation Date: 20-April, 2020. Registration State: NA. Contact Details. Email Address: Login to see email details: Registered Office Address: NA, Australia: …
Getcompanydetails.comGlyscend | VentureRadar
" Glyscend, Inc. is a venture-backed biopharmaceutical company developing novel orally-delivered compounds that work on targets inside the GI tract to treat a variety of metabolic disorders, including T2D. Glyscend’s polymer technology platform evolved from research at Johns Hopkins University, where scientists were evaluating the mechanisms that result in …
Ventureradar.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| mynudies.com | key-systems.net | -2 Years, -17 Days |
| 9to6linux.com | namecheap.com | 1 Year, 356 Days |
| stpeter.org | publicdomainregistry.com | -1 Years, -225 Days |
| thewechatagency.com | ovh.com | -1 Years, -215 Days |
| deonoystercompany.com | godaddy.com | 98 Days |
| thefrenchtown.com | godaddy.com | -1 Years, -333 Days |
| brownrunningclub.com | domains.google.com | -2 Years, -250 Days |
| conecaonline.info | publicdomainregistry.com | -1 Years, -241 Days |
| mtwhy.com | namecheap.com | 138 Days |
| 100fyy1.com | namecheap.com | -1 Years, -263 Days |